141 related articles for article (PubMed ID: 26970280)
1. Subgroup differences in 'brain-type' transferrin and α-synuclein in Parkinson's disease and multiple system atrophy.
Yoshihara A; Fukatsu M; Hoshi K; Ito H; Nollet K; Yamaguchi Y; Ishii R; Tokuda T; Miyajima M; Arai H; Kato T; Furukawa K; Arai H; Kikuchi A; Takeda A; Ugawa Y; Hashimoto Y
J Biochem; 2016 Aug; 160(2):87-91. PubMed ID: 26970280
[TBL] [Abstract][Full Text] [Related]
2. A unique glycan-isoform of transferrin in cerebrospinal fluid: A potential diagnostic marker for neurological diseases.
Hoshi K; Matsumoto Y; Ito H; Saito K; Honda T; Yamaguchi Y; Hashimoto Y
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2473-2478. PubMed ID: 28711405
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
4. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
Williams SM; Schulz P; Sierks MR
Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
[TBL] [Abstract][Full Text] [Related]
5. Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
Mov Disord; 2014 Nov; 29(13):1599-605. PubMed ID: 25258345
[TBL] [Abstract][Full Text] [Related]
6. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
[TBL] [Abstract][Full Text] [Related]
7. Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders.
Wang ZY; Han ZM; Liu QF; Tang W; Ye K; Yao YY
Int Psychogeriatr; 2015 Sep; 27(9):1429-38. PubMed ID: 25851548
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.
Gao L; Tang H; Nie K; Wang L; Zhao J; Gan R; Huang J; Zhu R; Feng S; Duan Z; Zhang Y; Wang L
Int J Neurosci; 2015; 125(9):645-54. PubMed ID: 25202803
[TBL] [Abstract][Full Text] [Related]
9. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein in the cerebrospinal fluid differentiates synucleinopathies (Parkinson Disease, dementia with Lewy bodies, multiple system atrophy) from Alzheimer disease.
Tateno F; Sakakibara R; Kawai T; Kishi M; Murano T
Alzheimer Dis Assoc Disord; 2012; 26(3):213-6. PubMed ID: 22037599
[TBL] [Abstract][Full Text] [Related]
11. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
Wang X; Yu S; Li F; Feng T
Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
[TBL] [Abstract][Full Text] [Related]
12. The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy.
Lee PH; Lee G; Park HJ; Bang OY; Joo IS; Huh K
J Neural Transm (Vienna); 2006 Oct; 113(10):1435-9. PubMed ID: 16465458
[TBL] [Abstract][Full Text] [Related]
13. CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls.
Oosterveld LP; Verberk IMW; Majbour NK; El-Agnaf OM; Weinstein HC; Berendse HW; Teunissen CE; van de Berg WDJ
Mov Disord; 2020 Feb; 35(2):288-295. PubMed ID: 31737952
[TBL] [Abstract][Full Text] [Related]
14. Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
Majbour NK; Vaikath NN; van Dijk KD; Ardah MT; Varghese S; Vesterager LB; Montezinho LP; Poole S; Safieh-Garabedian B; Tokuda T; Teunissen CE; Berendse HW; van de Berg WD; El-Agnaf OM
Mol Neurodegener; 2016 Jan; 11():7. PubMed ID: 26782965
[TBL] [Abstract][Full Text] [Related]
15. Measurements of auto-antibodies to α-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease.
Akhtar RS; Licata JP; Luk KC; Shaw LM; Trojanowski JQ; Lee VM
J Neurochem; 2018 Jun; 145(6):489-503. PubMed ID: 29500813
[TBL] [Abstract][Full Text] [Related]
16. Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity.
van Dijk KD; Bidinosti M; Weiss A; Raijmakers P; Berendse HW; van de Berg WD
Eur J Neurol; 2014 Mar; 21(3):388-94. PubMed ID: 23631635
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.
Hu X; Yang Y; Gong D
Neurol Sci; 2017 Mar; 38(3):407-414. PubMed ID: 27896490
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid and plasma distribution of anti-α-synuclein IgMs and IgGs in multiple system atrophy and Parkinson's disease.
Folke J; Rydbirk R; Løkkegaard A; Hejl AM; Winge K; Starhof C; Salvesen L; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T
Parkinsonism Relat Disord; 2021 Jun; 87():98-104. PubMed ID: 34020303
[TBL] [Abstract][Full Text] [Related]
19. Transferrin isoforms in cerebrospinal fluid and their relation to neurological diseases.
Murakami Y; Saito K; Ito H; Hashimoto Y
Proc Jpn Acad Ser B Phys Biol Sci; 2019; 95(5):198-210. PubMed ID: 31080188
[TBL] [Abstract][Full Text] [Related]
20. Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.
Eidson LN; Kannarkat GT; Barnum CJ; Chang J; Chung J; Caspell-Garcia C; Taylor P; Mollenhauer B; Schlossmacher MG; Ereshefsky L; Yen M; Kopil C; Frasier M; Marek K; Hertzberg VS; Tansey MG
J Neuroinflammation; 2017 Aug; 14(1):164. PubMed ID: 28821274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
